Key points from article :
Switzerland-based Maximon has announced the launch of its Longevity Co-Investment Fund (LCIF).
Already raised CHF 6 million at its first closing in the founder’s share class.
The Fund’s first investments include longevity supplement company AVEA and longevity advisory and big data company Biolytica.
LCIF will invest up to CHF 10 million in 10-12 start-ups over the next four years.
The fund will remain open for investors for the next 18+ months.
“We already have substantial subscription requests for the fund’s next closing”. - founding partner, Marc P Bernegger.
